Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 308: 123669, 2024 Mar 05.
Article in English | MEDLINE | ID: mdl-38006865

ABSTRACT

Derivatives of thiazole-pyrazole fused benzo-coumarin compounds were successfully synthesized and characterized, followed by a comprehensive spectroscopic investigation on various photophysical properties in different media. The multipronged approach using steady state and time resolved fluorescence spectroscopy pointed out the impact of substitution in the estimated spectroscopic and other physicochemical properties of the systems. Further, the evaluation of anti-acetylcholinesterase (anti-AChE) activity yielded significant insight into the therapeutic potential of the synthesized coumarinyl compounds for the treatment of Alzheimer's disease (AD). The findings revealed a non-competitive mode of inhibition mechanism, with an estimated IC50 value of 67.72 ± 2.00 nM observed for one of the investigated systems as AChE inhibitor. Notably, this value is even lower than that of an FDA-approved AD drug Donepezil (DON), indicating the enhanced potency of the coumarin derivatives in inhibiting AChE. Interestingly, significant diminution in inhibition was observed in presence of human serum albumin (HSA) as evidenced by the relative increase in IC50 value by 8 âˆ¼ 39 % in different cases, which emphasized the role of albumin proteins to control therapeutic efficacies of potential medications. In-depth spectroscopic and in-silico analysis quantified the nature of interactions of the investigated systems with HSA and AChE. Overall, the outcomes of this study provide significant understanding into the biophysical characteristics of novel thiazole-pyrazole fused benzo-coumarin systems, which could aid in the development of new cholinergic agents for the treatment of AD and materials based on coumarin motifs.


Subject(s)
Alzheimer Disease , Serum Albumin, Human , Humans , Cholinesterase Inhibitors/pharmacology , Cholinesterase Inhibitors/chemistry , Molecular Docking Simulation , Cholinergic Antagonists/pharmacology , Cholinergic Antagonists/therapeutic use , Thiazoles/pharmacology , Thiazoles/chemistry , Coumarins/pharmacology , Coumarins/chemistry , Spectrometry, Fluorescence , Pyrazoles/pharmacology , Alzheimer Disease/drug therapy , Structure-Activity Relationship
2.
J Phys Chem A ; 126(4): 546-556, 2022 Feb 03.
Article in English | MEDLINE | ID: mdl-35050595

ABSTRACT

Repurposing of existing drugs toward new therapeutic use(s) has become an emergent area of research in current times. In this context, the antioxidant behavior of eight cholinergic drugs used in the treatment of Alzheimer's disease (AD) was investigated theoretically. The low bond dissociation enthalpy values in all of the compounds advocated for the hydrogen atom transfer mechanism toward the observed antioxidant behavior. The kinetic study for the reaction of the drugs with hydroperoxyl radicals indicated an indirect reaction path owing to the presence of pre- and postreaction complexes. In some cases, the rate constant for the H-abstraction reaction (k = 2.8 × 103 L mol-1 s-1) is found to be close to that of a well-known non-phenolic antioxidant, α-terpinene (k = 4.3 × 103 L mol-1 s-1). Quantification of charge transfer character among the drugs with DNA bases and molecular docking calculations confirmed the groove binding model and predicted the drugs to be safe from DNA damage. A theoretical evaluation of the mechanistic details governing the antioxidant property along with the proven stress reversal ability of these AD drugs provided new insights to design and develop more efficient drugs with dual therapeutic potential.


Subject(s)
Alzheimer Disease , Pharmaceutical Preparations , Alzheimer Disease/drug therapy , Antioxidants , Cholinergic Agents/therapeutic use , Humans , Molecular Docking Simulation
3.
J Phys Chem A ; 125(32): 6964-6975, 2021 Aug 19.
Article in English | MEDLINE | ID: mdl-34372657

ABSTRACT

Excited state deactivation properties and the effects of solvent hydrogen bonding (HB) on the photophysical behavior of 2,2'-dypyridylamine (DPyA) were investigated by steady state and time-resolved fluorescence experiments, molecular docking, and density functional theory (DFT) calculations. In addition to the polarity effect, the contributions of solvent HB donation (HBD) acidity and HB acceptance (HBA) basicity to modulate the solvatochromic spectral properties were estimated from multiparametric linear regression analysis using Kamlet-Taft (KT) and Catalán formalisms. The importance of C-N bond torsion, leading to the trans → cis conversion, was manifested by substantial increase in DPyA fluorescence yield in the presence of cyclodextrin (CD) and glycerol. The unusually low fluorescence yield in aqueous medium was explained on the basis of synergistic effect of solvent hydrogen bonding combined with excited state conformational isomerization, which renders DPyA to be an excellent environment sensitive fluorescence reporter. The experimental results were verified with structural insights obtained from DFT calculations at B3LYP/6-311++G(d,p) level and construction of potential energy surface (PES) in the ground state as well as in the excited states.

SELECTION OF CITATIONS
SEARCH DETAIL
...